FDA Reopens Comments On Drug Ad Rule In New Study's Wake
The U.S. Food and Drug Administration on Friday reopened the comment period for its proposed amendments to its regulations on direct-to-consumer TV and radio ads for prescription drugs, citing the entry...To view the full article, register now.
Already a subscriber? Click here to view full article